High mortality by nosocomial infections caused by carbapenem-resistant P. aeruginosa in a referral hospital in Brazil: facing the perfect storm
Open Access
- 1 December 2020
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 69 (12) , 1388-1397
Abstract
Introduction. Carbapenem-resistant Pseudomonas aeruginosa is responsible for increased patient mortality. Gap Statement. Five and 30 day in-hospital all-cause mortality in patients with P. aeruginosa infections were assessed, followed by evaluations concerning potential correlations between the type III secretion system (TTSS) genotype and the production of metallo-β-lactamase (MBL). Methodology. This assessment comprised a retrospective cohort study including consecutive patients with carbapenem-resistant infections hospitalized in Brazil from January 2009 to June 2019. PCR analyses were performed to determine the presence of TTSS-encoding genes and MBL genes. Results. The 30-day and 5-day mortality rates for 262 patients were 36.6 and 17.9 %, respectively. The unadjusted survival probabilities for up to 5 days were 70.55 % for patients presenting exoU-positive isolates and 86 % for those presenting exo-negative isolates. The use of urinary catheters, as well as the presence of comorbidity conditions, secondary bacteremia related to the respiratory tract, were independently associated with death at 5 and 30 days. The exoS gene was detected in 64.8 % of the isolates, the presence of the exoT and exoY genes varied and exoU genes occurred in 19.3 % of the isolates. The exoU genotype was significantly more frequent among multiresistant strains. MBL genes were not detected in 92 % of the isolates. Conclusions. Inappropriate therapy is a crucial factor regarding the worse prognosis among patients with infections caused by multiresistant P. aeruginosa , especially those who died within 5 days of diagnosis, regardless of the genotype associated with TTSS virulence.Keywords
Funding Information
- FAPEMIG (APQ-04062-17)
- CNPq (428397/2018-2)
This publication has 39 references indexed in Scilit:
- Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patientsBurns, 2012
- Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosaPLOS ONE, 2012
- Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)Diagnostic Microbiology and Infectious Disease, 2012
- Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*Critical Care Medicine, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infectionInfection, 2011
- The type III secretion system of Pseudomonas aeruginosa: infection by injectionNature Reviews Microbiology, 2009
- Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospitalEnfermedades Infecciosas y Microbiología Clínica, 2009
- Role of Pseudomonas aeruginosa type III effectors in diseaseCurrent Opinion in Microbiology, 2009
- Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa BacteremiaAntimicrobial Agents and Chemotherapy, 2007